Skip to main content Back to Top
Advertisement

CMS Audits of Pharmacy Residency Programs – What You Need to Know Now

Broadcast Date: March 5, 2024

 


Subscribe on iTune Podcasts
Listen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast will provide members an overview of the impact of CMS audit practices on pharmacy residency programs. We’ll cover the challenges audits have created, how programs can prepare and protect themselves, and ongoing ASHP advocacy efforts to protect these programs. 

SPEAKERS

Jillanne Schulte Wall Jillanne Schulte Wall, JD, (she/her) is the senior director of health & regulatory policy for the American Society of Health-System Pharmacists (ASHP) in Bethesda, MD. She serves as ASHP’s primary liaison to federal regulatory agencies and, in conjunction with other members of the Government Relations team, develops and communicates of ASHP’s positions on federal and state laws, regulations, and guidance related to the profession of pharmacy.  Additionally, Jillanne works closely with stakeholders in pharmacy, medicine, manufacturing, and patient advocacy on legislative and regulatory issues of importance to ASHP members. 

Tom KrausTom Kraus, JD, MHS serves as the vice president of government relations for ASHP. Kraus previously served as the deputy staff director of health on the U.S. Senate Committee on Health, Education, Labor and Pensions under Senators Edward Kennedy and Tom Harkin, where he was instrumental in the passage of key legislation, including Food and Drug Administration (FDA) drug and food safety reforms and user fee legislation, the American Recovery and Reinvestment Act, and the Affordable Care Act. Following his time on Capitol Hill, he joined the FDA, where he served as Chief of Staff and Associate FDA Commissioner for Legislation. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.  
ASHP 2020 Summer Sessions

ASHP Pharmacy Futures 2024

Welcome to our new format!
Start Here
Link the whole card
Prescriptions

Drug Shortages

Your first stop for information and resources on drug products, their availability, and management
Learn More
Link the whole card